Buyers widening their own doors: demand already secured, far-side receiving constraint now being cleared
The model's full reasoning — Q4 2023 call → NO我们根据提供的财报电话会议记录来判断。问题问的是管理层是否传达出公司已经有已确保的业务或需求,但交付的瓶颈在于客户方的接收、安装、认证等能力,并且客户方正在努力解决这些准备,相关业务大多还在未来。 分析记录内容: - 管理层提到项目延迟是由于“three of our existing customers”的“delays out of our control”,这些延迟导致收入确认时间推迟到2024年下半年。 - 他们提到“the majority of the revenues causing our miss of earlier guidance in 2023 are all expected to be booked during 2024”,表明这些业务已经存在,只是延迟。 - 但管理层没有明确描述客户方正在做什么准备来接收,只是说延迟是“customer-driven delays”。没有提到客户正在建设、安装、认证等。 - 管理层提到“we are engaged in more than $100 million of opportunities”,但那是机会,不是已确保的。 - 关于现有客户,他们提到“recently signed deals with two major railroads for AI subscription and support services contracts”,但那是已签署的,不是延迟。 - 整体上,管理层将延迟归因于客户,但没有描述客户正在积极准备接收。他们只是说延迟是“out of our control”,并预期2024年能确认收入,但没有说明客户正在做什么来消除延迟。 因此,不满足条件(3):没有描述客户方正在清除约束。所以答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
MKC · Q2 2018 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive, install, etc., and those counterpartie...**NO** The transcript describes a situation where McCormick has already won shelf-space changes and distribution improvements from retailers (customers have accepted the recommendations), but implementation is delayed due to retailers' own operational reset windows and competitor product sell-through. This is framed as a temporary, ongoing industry practice rather than a binding constraint being actively cleared right now to unlock a meaningfully larger volume of already-secured business. Management presents it as part of their category-management progress with runway ahead, not as counterparties clearing a receiving-side bottleneck that is already underway and will drive the bulk of the upside.
BIIB · Q2 2017 → YESThe question is about whether management conveys that they already have secured demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties are already ...YES The transcript shows management conveying exactly this situation for SPINRAZA. Demand is already secured and arriving: “significant uptake in the U.S.” with “strong demand across patient types” and “roughly two third of patients treated to date having Type 2 or Type 3 SMA.” The binding constraint is on 60% of Type 2 patients who have had spinal surgery, creating intrathecal administration challenges on the receiving side.
BXP · Q1 2022 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties ...YES The transcript shows management conveying secured demand through signed leases totaling over 975,000 square feet on vacant space that have not yet commenced occupancy, plus an additional 1.3 million square feet in active negotiations and over 750,000 square feet in the development pipeline.